Open Access Open Access  Restricted Access Access granted  Restricted Access Subscription or Fee Access

Vol 29, No 9 (2018)

Articles

Features of the development of cognitive impairment in patients with type 2 diabetes mellitus and metabolic syndrome

Shishkova V., Kapustina L.

Abstract

Type 2 diabetes mellitus (DM) is one of the most important independent risk factors for cognitive impairment (CN) and dementia. The presence of possible CN or its development in a patient with DM should be taken into account when choosing the right combination therapy. Each patient with DM should be treated individually, by taking into consideration the clinical features and possible complications, as well as the presence of comorbid vascular diseases. When choosing cognitive function-improving drugs, it is necessary to keep in mind their other positive as well as direct effects, their tolerability and the possibility of their safe combination in combination therapy.
Vrach. 2018;29(9):3-10
pages 3-10 views

Mechanisms of neuroplasticity in patients with diabetes mellitus

Matveeva M., Samoilova Y., Zhukova N., Rotkank M., Leiman O.

Abstract

The paper presents the issues of neuroplasticity in patients with diabetes mellitus and in experimental models, as well as the effect of insulin, the variability of glycemia, and the level of brain-derived neurotrophic factor on plasticity.
Vrach. 2018;29(9):10-13
pages 10-13 views

Use of muscle relaxants in nonspecific lower back pain

Kotova O., Artemenko A., Akarachkova E., Belyaev A.

Abstract

The priority in the management of a patient with back pain is its earliest possible relief. It is important to involve the patient in a set of remedial and rehabilitation treatments and to prevent chronic pain syndrome. Factors, such as pain intensity and duration, concomitant diseases, and ongoing therapy tolerability, play a crucial role in the choice of therapy. Muscle relaxants can alleviate or even eliminate excessive muscle tension. Their co-administration with nonsteroidal anti-inflammatory drugs makes it possible to lower the dosage of the latter and the risk of side effects.
Vrach. 2018;29(9):13-17
pages 13-17 views

Cognitive dysfunction in the overexcitation of brain structures

Volobuev A., Pyatin V., Romanchuk N., Bulgakova S., Davydkin I.

Abstract

The brain memory mechanism is a network of cyclic neural circuits (CNCs). When there is insufficient γ-aminobutyric acid secretion in the brain, many CNCs are switched off from the memory mechanism, which causes cognitive dysfunction. This is one of the causes of memory impairment in AlzheimePs disease and senile dementia of the Alzheimer type.
Vrach. 2018;29(9):17-20
pages 17-20 views

Biomechanics of the systemic circulation in type 1 and 2 diabetes mellitus

Garanin A., Bulgakova S., Zakharova N., Lebedeva E.

Abstract

In type 1 and 2 diabetes mellitus, the contractility of systemic arterial circulation is impaired, the stiffness of the arterial wall increases, and the pacemaker activity of the heart and its effect on the vascular bed change, which contributes to arterial remodeling.
Vrach. 2018;29(9):21-25
pages 21-25 views

The relationship between depression and cognitive impairment in the russian population over 65 years of age: results of the CRYSTAL study

Turusheva A., Frolova E.

Abstract

The results of the Crystal study have shown the high prevalence of cognitive impairment (CI) in people aged over 65 years. About half of CI cases may be reversible and associated with concomitant depression.
Vrach. 2018;29(9):26-30
pages 26-30 views

Hypovitaminosis D and chronic pain

Koloskova A., Vorobyeva O.

Abstract

Currently, there is a substantial evolution of knowledge about the physiological role of vitamin D. Its receptors are assumed to be involved in the mechanisms of pain generation. There have been a large number of studies revealing the significance of hypovitaminosis D primarily in chronic pain syndromes and diseases, in which musculoskeletal factors are dominant in the formation of pain. The paper highlights the present-day views on the association of pain with vitamin D levels in the body and reviews the studies conducted in this area.
Vrach. 2018;29(9):31-36
pages 31-36 views

Combination therapy for polyneuropathy in patients with type 2 diabetes mellitus

Pashkova I., Potupchik T., Petrova M., Veselova O., Gatskikh I., Shalda T.

Abstract

The paper provides an overview of the use of metabolic drug cocarnit in patients with diabetic polyneuropathy (DPNP). It considers the pathogenesis of DPNP in light of the development of oxidative stress in diabetes mellitus and the effect of medicines that are contained in cocarnit on its manifestation.
Vrach. 2018;29(9):37-43
pages 37-43 views

Cellular chronoblockers in multimodal programmes for the prevention of cognitive deficit

Gashimova U., Korshun E., Zhaboeva S., Satardinova E.

Abstract

The paper considers the target points of application of cellular chronoblockers (succinic acid, guarana, taurine, selenium, L-arginine, and ß-alanine) in the multimodal programs to prevent cognitive deficit. It shows the effects of these substances in improving cognitive abilities.
Vrach. 2018;29(9):43-47
pages 43-47 views

Age-related and situational depression

Ilnitsky A., Proshchaev K.

Abstract

The paper considers age-related and situational depression as a special condition in the anti-aging medicine clinic. It is important that age-related and situational depression is the background for the development of anxiety-depressive syndrome as an individual nosological entity that requires the correction corresponding to the patients status, as well as the follow-up by a psychotherapist or a psychiatrist. The paper presents the questionnaires and scales, which can be used in the anti-aging medicine clinic if anxiety and depression are suspected.
Vrach. 2018;29(9):48-49
pages 48-49 views

Features of the psychological and cognitive status of those who are treated for age-related cataract

Shchekaturov A., Filimonov M.

Abstract

The paper presents data on the prevalence of senile asthenia among only the elderly people who have been treated for age-related cataracts and assesses quality of life in patients from this group.
Vrach. 2018;29(9):50-52
pages 50-52 views

Treatment-induced diabetic neuropathy (Ellenberg syndrome)

Maksimova N., Moshenina S.

Abstract

Diabetic peripheral neuropathy is the most common complication associated with diabetes mellitus, which is represented by heterogeneous conditions that differ in the site of a lesion in the nervous system lesion and manifestations. In his/her practice, a physician can encounter neuropathy induced by rapid improvements of glycemic control in individuals with long-term hyperglycemia. The importance of achieving glycemia as close to physiological range is undisputed, but the risk of severe pain syndrome in the lower extremities in the presence of relative hypoglycemia necessitates an individual approach in compliance with the tactics of gradual compensation of carbohydrate metabolism.
Vrach. 2018;29(9):53-57
pages 53-57 views

The implementation of cardioprotection with nicorandil from periprocedural damage during elective percutaneous coronary interventions in patients with stable coronary heart disease

Gostishchev R., Soboleva G., Samko A., Minasyan A.

Abstract

The purpose of the study is to demonstrate such an effect of the nicorandil like the pharmacological preconditioning in patients with stable coronary heart disease during elective percutaneous coronary intervention.
Vrach. 2018;29(9):57-61
pages 57-61 views

Correction of cognitive impairment in somatic disease at the sanatorium-resort stage

Vorontsov S., Makarova I.

Abstract

The authors have estimated the dynamics of cognitive impairment in hypertensive patients with risk factors for chronic kidney disease at the stage of sanatoriumresort stage.
Vrach. 2018;29(9):62-64
pages 62-64 views

The age of patients and the dynamics of ECG in neuroleptic cardiomyopathy

Volkov V.

Abstract

The side cardiotoxic effect of antipsychotics, which leads to cardiac disease, rather than an age factor, has been established to have a decisive impact on electrocardiographic changes in the development of neuroleptic cardiomyopathy.
Vrach. 2018;29(9):65-67
pages 65-67 views

Use of pharmacological agents to preserve, restore, and improve the performance of young hockey players

Mikhno L., Levshin I., Polikarpochkin A., Ellstratov D., Strukov V., Poluboyarinov P., Petrova E.

Abstract

The paper presents pharmacological agents, the use of which is indicated in sports practice to improve the body's overall tolerance to high physical activity, to intensify recovery processes, and to prevent the negative effects of inadequate physical stress on the body. The biomedical support of a training process in young hockey players should ensure that pharmacological agents are reasonably used.
Vrach. 2018;29(9):67-71
pages 67-71 views

Second-year students’ functional status during the examination session

Vesnina T., Rybina Y., Tkachuk A.

Abstract

The paper considers the time course of changes in the current functional status of students during their examination session.
Vrach. 2018;29(9):72-74
pages 72-74 views

Evaluation of the efficiency of running impulse magnetic field therapy with an ALMAG+ apparatus in treatment of varicose vein disease

Byalovsky Y., Ivanov A., Larinsky N., Sekirin A.

Abstract

The paper considers the efficacy of running impulse magnetic field therapy with an ALMAG apparatus in the combination treatment of patients with lower extremity varicose vein disease.
Vrach. 2018;29(9):74-79
pages 74-79 views

The world's strongest antimicrobial alkaloids in the composition of antiseptic Sanguiritrin® (0.2% alcohol solution)

Rubleva O.

Abstract

This review was devoted to the herbal antiseptic Sanguiritrin®, which consists of 2 of the 12 strongest antimicrobial alkaloids in the world (sanguinarine, chelerythrine). The antimicrobial and antiinflammatory effect of the drug is discussed. Its use with a preventive and curative purpose for infectious inflammatory diseases of the skin and mucous membranes in dentistry, otolaryngology, dermatology, neonatology, gynecology and surgery is described.
Vrach. 2018;29(9):79-84
pages 79-84 views

Rationale for the use of hepatoprotective agents in the treatment of psoriasis

Denisova E., Dvoryankova E., Denieva M., Sobolev V., Korsunskaya I.

Abstract

Current studies indicate comorbidity of psoriasis and various hepatobiliary disorders. Concurrence of psoriasis and non-alcoholic fatty liver disease is most frequently encountered. The paper describes common components in the pathogenesis of these diseases, which is one of the reasons for incorporating hepatoprotective agents in the combination therapy of psoriasis. The authors investigation demonstrates the advantage of a drug containing essential phospholipids and glycyrrhizic acid over conventional therapy with hepatoprotective drugs.
Vrach. 2018;29(9):85-88
pages 85-88 views

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies